These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18768187)

  • 41. MM3-ELISA evaluation of coproantigen release and serum antibody production in sheep experimentally infected with Fasciola hepatica and F. gigantica.
    Valero MA; Ubeira FM; Khoubbane M; Artigas P; Muiño L; Mezo M; Pérez-Crespo I; Periago MV; Mas-Coma S
    Vet Parasitol; 2009 Jan; 159(1):77-81. PubMed ID: 19019548
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Time-course analysis of coproantigens in rats infected and challenged with Fasciola hepatica.
    Paz-Silva A; Pedreira J; Sánchez-Andrade R; Suárez JL; Díaz P; Panadero R; Díez-Baños P; Morrondo P
    Parasitol Res; 2002 Jun; 88(6):568-73. PubMed ID: 12107481
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vaccination of goats with recombinant galectin antigen induces partial protection against Haemonchus contortus infection.
    Yanming S; Ruofeng Y; Muleke CI; Guangwei Z; Lixin X; Xiangrui L
    Parasite Immunol; 2007 Jun; 29(6):319-26. PubMed ID: 17518950
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Persistent immune responses in late infection and after treatment in experimental Schistosoma bovis infections in goats.
    Sörén K; Monrad J; Johansen MV; Lindberg R
    Res Vet Sci; 2009 Jun; 86(3):472-8. PubMed ID: 19027127
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistochemical study of the local immune response to Fasciola hepatica in primarily and secondarily infected goats.
    Pérez J; de las Mulas JM; De Lara FC; Gutierrez-Palomino PN; Becerra-Martel C; Martínez-Moreno A
    Vet Immunol Immunopathol; 1998 Aug; 64(4):337-48. PubMed ID: 9764726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protection against Fasciola hepatica in rats with adult fluke antigen in Freund's adjuvant: influence of antigen batch, antigen dose and number of sensitising injections.
    Oldham G
    Res Vet Sci; 1983 Mar; 34(2):240-4. PubMed ID: 6856998
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral administration of a live Aro attenuated Salmonella vaccine strain expressing 14-kDa Schistosoma mansoni fatty acid-binding protein induced partial protection against experimental schistosomiasis.
    Pacheco LG; Zucconi E; Mati VL; Garcia RM; Miyoshi A; Oliveira SC; de Melo AL; Azevedo V
    Acta Trop; 2005 Aug; 95(2):132-42. PubMed ID: 15993833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glomerulonephritis in water buffaloes (Bubalus bubalis) naturally infected by Fasciola hepatica.
    Marques SM; Scroferneker ML; Edelweiss MI
    Vet Parasitol; 2004 Aug; 123(1-2):83-91. PubMed ID: 15265573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combined immunization using DNA-Sm14 and DNA-Hsp65 increases CD8+ memory T cells, reduces chronic pathology and decreases egg viability during Schistosoma mansoni infection.
    Espíndola MS; Frantz FG; Soares LS; Masson AP; Tefé-Silva C; Bitencourt CS; Oliveira SC; Rodrigues V; Ramos SG; Silva CL; Faccioli LH
    BMC Infect Dis; 2014 May; 14():263. PubMed ID: 24886395
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enteral vaccination of rats against Fasciola hepatica using recombinant cysteine proteinase (cathepsin L1).
    Kesik M; Jedlina-Panasiuk L; Kozak-Cieszczyk M; Płucienniczak A; Wedrychowicz H
    Vaccine; 2007 May; 25(18):3619-28. PubMed ID: 17289224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Flow cytometry analysis of leukocytes response in rats immunized and infected with Fasciola hepatica].
    Jedlina-Panasiuk L
    Wiad Parazytol; 2004; 50(3):477-81. PubMed ID: 16865956
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lymphocyte responses of rats vaccinated with cDNA encoding a phosphoglycerate kinase of Fasciola hepatica (FhPGK) and F. hepatica infection.
    Wesołowska A; Zawistowska-Deniziak A; Norbury LJ; Wilkowski P; Pyziel AM; Zygner W; Wędrychowicz H
    Parasitol Int; 2018 Feb; 67(1):85-92. PubMed ID: 28385589
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stability improvement of the fatty acid binding protein Sm14 from S. mansoni by Cys replacement: structural and functional characterization of a vaccine candidate.
    Ramos CR; Spisni A; Oyama S; Sforça ML; Ramos HR; Vilar MM; Alves AC; Figueredo RC; Tendler M; Zanchin NI; Pertinhez TA; Ho PL
    Biochim Biophys Acta; 2009 Apr; 1794(4):655-62. PubMed ID: 19150418
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Host-parasite relationships of Fasciola hepatica in the white mouse. VIII. Successful vaccination with culture incubate antigens and antigens from sonic disruption of immature worms.
    Lang BZ; Hall RF
    J Parasitol; 1977 Dec; 63(6):1046-9. PubMed ID: 592034
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma enzyme changes in goats infected with Fasciola hepatica and the effect of nitroxynil.
    Hughes DL; Treacher RJ; Harness E
    Res Vet Sci; 1973 Sep; 15(2):249-55. PubMed ID: 4803580
    [No Abstract]   [Full Text] [Related]  

  • 56. The addition of a new immunomodulator with the adjuvant adaptation ADAD system using fatty acid binding proteins increases the protection against Fasciola hepatica.
    López-Abán J; Nogal-Ruiz JJ; Vicente B; Morrondo P; Diez-Baños P; Hillyer GV; Martínez-Fernández AR; Feliciano AS; Muro A
    Vet Parasitol; 2008 May; 153(1-2):176-81. PubMed ID: 18308471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection model.
    Mossallam SF; Amer EI; Ewaisha RE; Khalil AM; Aboushleib HM; Bahey-El-Din M
    BMC Infect Dis; 2015 Mar; 15():147. PubMed ID: 25887456
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of Quil A adjuvant on the course of experimental Fasciola hepatica infection in sheep.
    Haçariz O; Sayers G; McCullough M; Garrett M; O'Donovan J; Mulcahy G
    Vaccine; 2009 Jan; 27(1):45-50. PubMed ID: 18977261
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genotypic characterization and species identification of Fasciola spp. with implications regarding the isolates infecting goats in Vietnam.
    Nguyen TG; Van De N; Vercruysse J; Dorny P; Le TH
    Exp Parasitol; 2009 Dec; 123(4):354-61. PubMed ID: 19733565
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pilot vaccination project for the control of hydatid disease in Matera province (southern Italy).
    Casulli A; Vitelli G; Santagada G; Pozio E
    Parassitologia; 2004 Dec; 46(4):421. PubMed ID: 16044706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.